CD9 and breast cancer: Tutanov et al., (2020) revealed the importance of the expression of ADAM10 at CD9-positive exosomes in the biodistribution of free plasma exosomes and blood cell-surface-associated vesicles in healthy women and in luminal breast cancer patients.